| Literature DB >> 27956423 |
Vasantha Rao Dola1, Awakash Soni2, Pooja Agarwal2, Hafsa Ahmad3, Kanumuri Siva Rama Raju4, Mamunur Rashid4, Muhammad Wahajuddin4, Kumkum Srivastava2, W Haq1, A K Dwivedi3, S K Puri2, S B Katti5.
Abstract
A novel 4-aminoquinoline derivative [(S)-7-chloro-N-(4-methyl-1-(4-methylpiperazin-1-yl)pentan-2-yl)-quinolin-4-amine triphosphate] exhibiting curative activity against chloroquine-resistant malaria parasites has been identified for preclinical development as a blood schizonticidal agent. The lead molecule selected after detailed structure-activity relationship (SAR) studies has good solid-state properties and promising activity against in vitro and in vivo experimental malaria models. The in vitro absorption, distribution, metabolism, and excretion (ADME) parameters indicate a favorable drug-like profile.Entities:
Keywords: 4-aminoquinoline; antimalarial agents; chloroquine resistant; quinolines
Mesh:
Substances:
Year: 2017 PMID: 27956423 PMCID: PMC5328577 DOI: 10.1128/AAC.01152-16
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191